Tıp Fakültesi / Faculty of Medicine

Permanent URI for this collectionhttps://hdl.handle.net/11727/1403

Browse

Filters

20181

Settings

Author: search.filters.author.Benli, SibelSubject: search.filters.subject.Autoimmune disease

Search Results

Now showing 1 - 1 of 1
  • No Thumbnail Available
    Item
    Ipilimumab Treatment Associated with Myasthenic Crises and Unfavorable Disease Course
    (2018) Derle, Eda; Benli, Sibel; 0000-0003-2122-1016; 0000-0002-9975-3170; 29948466; AAI-8830-2021; AAJ-4403-2021
    Ipilimumab, a monoclonal antibody targeting the cytotoxic T lymphocyte antigen-4 is a treatment option for metastatic melanoma. This receptor serves as an inhibitor receptor on T lymphocytes and blockage of these results predisposition to autoimmune diseases. The patients with autoimmune disorders were excluded in clinical trials and there is no sufficient data of the treatment on these patients who already have an autoimmune disorder. Here, we report a case of myasthenia gravis who was treated with ipilimumab and we presented the long-term prognosis of the patient after treatment.